This indicates that when buprenorphine receptor occupancy is sufficiently high, fentanyl is unable to activate the MOR and consequently will not cause additional respiratory depression on top of the mild respiratory effects of buprenorphine. The gene discussed is OPRM1; the disease is Respiratory insufficiency due to muscle weakness.